Egyptian International Pharmaceutical Industries Co. PHAR
المصرية الدولية للصناعات الدوائية - ايبيكو
Health Care & PharmaceuticalsEgyptian Exchange
112.21 EGP
-0.24%
Close of Thu 12 Nov 2026
- Market value
- EGP 19.00bn
- Highest and lowest close in a year
- 69.64 – 160.18
- Shares traded in the session
- 625,196
A chart of every session, the financial statements, the nine checks and filing alerts. Free, with your e-mail and a six-digit code.
About the company
Egyptian International Pharmaceutical Industries (EIPICO) is a pharmaceutical company established in December 1980, based in 10th of Ramadan, Egypt, and listed on the EGX since September 1995. It is controlled by the Arab Company for Drug Industries and Medical Appliances (51.345%). Its holdings include Egyptian International Company for Ampoules (98.6286%), EIPICO Tech for Medecines (98.6%), Al Batterjee Factory (30.0%), Arab API (30.0%), and Medical Union Pharmaceuticals (9.77%).
Its record at the exchange
Across 569 filings between 2010 and 2026, EIPICO recorded 63 consecutive profitable reported periods from 2013 to 2026 without a single loss-making period. Annual net results ranged from a low of 330 million EGP in FY 2013 to a peak of 1,458 million EGP in FY 2025. Its exchange record includes 3 capital increases, alongside 14 trading suspensions and 13 resumptions, peaking with 49 total filings in 2023.
Its latest filings at the exchange
- ResultsEgyptian International Pharmaceuticals (EIPICO) (PHAR.CA) Reports its Financial Results (Standalone) for the Period from 01/01/2026 to 30/09/2026
- ResultsEgyptian International Pharmaceuticals (EIPICO) (PHAR.CA) Reports its Financial Results (Consolidated) for the Period from 01/01/2026 to 30/09/2026
- Board decisionsEgyptian International Pharmaceuticals (EIPICO) (PHAR.CA) - Decisions of the BoD Meeting
- Board decisionsEgyptian International Pharmaceuticals (EIPICO) (PHAR.CA) - Disclosure Form for the BoD & the Shareholders' Structure
- ResultsEgyptian International Pharmaceuticals (EIPICO) (PHAR.CA) Reports its Financial Results (Consolidated) for the Period from 01/01/2026 to 30/06/2026
- ResultsEgyptian International Pharmaceuticals (EIPICO) (PHAR.CA) Reports its Financial Results (Standalone) for the Period from 01/01/2026 to 30/06/2026
- Trading resumedResume of Trading on Egyptian International Pharmaceuticals (EIPICO) (PHAR.CA)
- Board decisionsEgyptian International Pharmaceuticals (EIPICO) (PHAR.CA) - Decisions of the Board of Directors
Insider trades in the exchange’s bulletin
As the exchange publishes them in each session’s bulletin: the trader’s capacity, not their name. Each row opens the bulletin itself.
- Insider / Board Sold9,000 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Sold6,000 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Sold10,000 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Sold19,000 (0.01% of the company)Bulletin ↗
- Insider / Board Sold1,000 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Sold5,000 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Sold5,000 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Sold2,000 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Sold3,800 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Sold200 (less than 0.01% of the company)Bulletin ↗
Other companies in Health Care & Pharmaceuticals
- GlaxoSmithKline S.A.E. BIOC
- Cleopatra Hospital Company CLHO
- El-Nile Co. for Pharmaceuticals & Chemical Industries NIPH
- Alexandria New Medical Center Co. AMES
- Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda RMDA
- Ibnsina Pharma ISPH
- Minapharm Pharmaceuticals MIPH
- Kahira Pharmaceuticals & Chemical Industries Co. CPCI
- Memphis Pharmaceutical & Chemical Industries MPCI
- Alexandria Company for Pharmaceuticals and Chemical Industries AXPH
- Nozha International Hospital NINH
- October Pharma Co. OCPH
Page updated with the data of 15 Nov 2026.